Targeted Therapy for Metastatic HR+/HER2- Breast Cancer: CDK4/6 and PI3K
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Hope S. Rugo, MD
Disclosure
Hope S. Rugo, MD discloses no such relationships exist
Accreditation
NA
